Dense Breasts

What Do Our Patients Need to Be Told and Why?

Alyssa D. Throckmorton, Deborah Rhodes, Kevin S. Hughes, Amy C Degnim, Diana Dickson-Witmer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

More than 50 % of states have state-mandated density notification for patients with heterogeneously or extremely dense breasts. Increased breast density carries a risk of masking a cancer and delaying diagnosis. Supplemental imaging is optional and often recommended for certain patients. There are no evidence-based consensus guidelines for screening patients with density as their only risk factor. Breast cancer risk assessment and breast cancer prevention strategies should be discussed with women with dense breasts.

Original languageEnglish (US)
Pages (from-to)3119-3127
Number of pages9
JournalAnnals of Surgical Oncology
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Breast
Breast Neoplasms
Guidelines
Neoplasms
Breast Density

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Dense Breasts : What Do Our Patients Need to Be Told and Why? / Throckmorton, Alyssa D.; Rhodes, Deborah; Hughes, Kevin S.; Degnim, Amy C; Dickson-Witmer, Diana.

In: Annals of Surgical Oncology, Vol. 23, No. 10, 01.10.2016, p. 3119-3127.

Research output: Contribution to journalArticle

Throckmorton, Alyssa D. ; Rhodes, Deborah ; Hughes, Kevin S. ; Degnim, Amy C ; Dickson-Witmer, Diana. / Dense Breasts : What Do Our Patients Need to Be Told and Why?. In: Annals of Surgical Oncology. 2016 ; Vol. 23, No. 10. pp. 3119-3127.
@article{7a8812a46bb847e9b4d261e5cbcfcdad,
title = "Dense Breasts: What Do Our Patients Need to Be Told and Why?",
abstract = "More than 50 {\%} of states have state-mandated density notification for patients with heterogeneously or extremely dense breasts. Increased breast density carries a risk of masking a cancer and delaying diagnosis. Supplemental imaging is optional and often recommended for certain patients. There are no evidence-based consensus guidelines for screening patients with density as their only risk factor. Breast cancer risk assessment and breast cancer prevention strategies should be discussed with women with dense breasts.",
author = "Throckmorton, {Alyssa D.} and Deborah Rhodes and Hughes, {Kevin S.} and Degnim, {Amy C} and Diana Dickson-Witmer",
year = "2016",
month = "10",
day = "1",
doi = "10.1245/s10434-016-5400-3",
language = "English (US)",
volume = "23",
pages = "3119--3127",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Dense Breasts

T2 - What Do Our Patients Need to Be Told and Why?

AU - Throckmorton, Alyssa D.

AU - Rhodes, Deborah

AU - Hughes, Kevin S.

AU - Degnim, Amy C

AU - Dickson-Witmer, Diana

PY - 2016/10/1

Y1 - 2016/10/1

N2 - More than 50 % of states have state-mandated density notification for patients with heterogeneously or extremely dense breasts. Increased breast density carries a risk of masking a cancer and delaying diagnosis. Supplemental imaging is optional and often recommended for certain patients. There are no evidence-based consensus guidelines for screening patients with density as their only risk factor. Breast cancer risk assessment and breast cancer prevention strategies should be discussed with women with dense breasts.

AB - More than 50 % of states have state-mandated density notification for patients with heterogeneously or extremely dense breasts. Increased breast density carries a risk of masking a cancer and delaying diagnosis. Supplemental imaging is optional and often recommended for certain patients. There are no evidence-based consensus guidelines for screening patients with density as their only risk factor. Breast cancer risk assessment and breast cancer prevention strategies should be discussed with women with dense breasts.

UR - http://www.scopus.com/inward/record.url?scp=84978141626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978141626&partnerID=8YFLogxK

U2 - 10.1245/s10434-016-5400-3

DO - 10.1245/s10434-016-5400-3

M3 - Article

VL - 23

SP - 3119

EP - 3127

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 10

ER -